Literature DB >> 9987625

Risk factors for visual field damage progression in normal-tension glaucoma eyes.

L Daugeliene1, T Yamamoto, Y Kitazawa.   

Abstract

BACKGROUND: This study was carried out to evaluate intraocular or systemic factors associated with the visual field damage progression in eyes with normal-tension glaucoma (NTG). PATIENTS AND METHODS: Forty-seven NTG eyes with a minimum follow-up of 5 years were enrolled into the retrospective study. A stepwise regression analysis was performed to correlate the visual field damage progression, expressed as the mean deviation (MD) change per year, with several independent clinical factors including age, history of disc hemorrhage, initial MD, mean intraocular pressure (IOP), peak IOP, diurnal fluctuation of IOP, presence of a beta zone of peripapillary atrophy, and use of Ca(2+)-channel blockers.
RESULTS: Statistical analysis revealed that non-use of Ca(2+)-channel blockers (P = 0.01), peripapillary atrophy (P = 0.03) and disc hemorrhage (P = 0.04) were associated with visual loss progression.
CONCLUSIONS: Risk factors unrelated to IOP were suggested to be associated with progression of visual field loss. Systemic use of Ca(2+)-channel blockers has a favorable effect on visual field prognosis in NTG eyes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987625     DOI: 10.1007/s004170050203

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  13 in total

1.  Optical coherence tomography disc assessment in optic nerves with peripapillary atrophy.

Authors:  Edward Lai; Gadi Wollstein; Lori Lyn Price; Lelia A Paunescu; Paul C Stark; James G Fujimoto; Joel S Schuman
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 Nov-Dec

2.  Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up.

Authors:  Shinya Komori; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-17       Impact factor: 3.117

3.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

4.  Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma.

Authors:  Takako Nakagami; Yoshio Yamazaki; Fukuko Hayamizu
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

5.  Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

6.  Peripapillary atrophy in the unilateral exfoliation syndrome.

Authors:  Päivi Puska; Mika Harju; Ron Liebkind
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-28       Impact factor: 3.117

7.  Short-term fluctuation of intraocular pressure is higher in patients with pseudoexfoliation syndrome despite similar mean intraocular pressure: a retrospective case-control study.

Authors:  Cord Huchzermeyer; Folkert Horn; Robert Lämmer; Christian Y Mardin; Anselm G M Jünemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-14       Impact factor: 3.117

8.  Latanoprost nonresponders with open-angle glaucoma in the Japanese population.

Authors:  Yoko Ikeda; Kazuhiko Mori; Takeshi Ishibashi; Shigeta Naruse; Nobuko Nakajima; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

9.  Progression rate of total, and upper and lower visual field defects in open-angle glaucoma patients.

Authors:  Takeo Fukuchi; Takaiko Yoshino; Hideko Sawada; Masaaki Seki; Tetsuya Togano; Takayuki Tanaka; Jun Ueda; Haruki Abe
Journal:  Clin Ophthalmol       Date:  2010-11-18

10.  Intereye comparison of ocular factors in normal tension glaucoma with asymmetric visual field loss in Korean population.

Authors:  Eun Jung Lee; Jong Chul Han; Changwon Kee
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.